Dec 18, 2017 ... One of the biggest U.S. Supreme Court decisions of the past term was the court's June decision in Bristol-Myers Squibb Co. v. Superior Court of California, which severely curtailed the exercise of specific jurisdiction over out-of-state corporate defendants. 137 S. Ct. 1773 (2017). The decision has already ...
Case opinion for US 7th Circuit WILLIAMS v. BRISTOL MYERS SQUIBB COMPANY. Read the Court's full decision on FindLaw.
Case opinion for US 1st Circuit COLLAZO v. BRISTOL MYERS SQUIBB MANUFACTURING INC. Read the Court's full decision on FindLaw.
Zenith Laboratories, Inc., Plaintiff-appellant, v. Bristol-myers Squibb Company, Defendant-appellee, 19 F.3d 1418 (Fed. Cir. 1994) case opinion from the U.S. Court of Appeals for the Federal Circuit.
Jan 5, 2018 ... On December 5, 2017, the Federal Circuit held oral argument in Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, 17-1694. The case comes on appeal from an IPR decision where the Board declined to find U.S. Patent No. 8,476,239 (“the ʼ239 patent”) unpatentable as obvious. The ʼ239 ...
Dec 5, 2017 ... Parties, docket activity and news coverage of federal case Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, case number 17-1694, from Appellate - Federal Circuit Court.
Dec 8, 2017 ... Just this past June, in Bristol-Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017) (“BMS”), the U.S. Supreme Court addressed the extent to which a defendant's forum-related contacts must relate to the plaintiff's claims in order to establish specific jurisdiction. BMS involved product liability claims ...
Visiting Attorney in Kirkland & Ellis LLP's Corporate - Mergers & Acquisitions Practice. The six-month reverse secondment program concluded in October 2012 , and I returned in November 2012 to my position as Counsel, Transactional Practice Group - Bristol-Myers Squibb.